awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33356339-170424F5-AF79-4587-B12C-295F7FD9686C
Q33356339-170424F5-AF79-4587-B12C-295F7FD9686C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33356339-170424F5-AF79-4587-B12C-295F7FD9686C
Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!
P2860
Q33356339-170424F5-AF79-4587-B12C-295F7FD9686C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33356339-170424F5-AF79-4587-B12C-295F7FD9686C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41e47297435a54b26ac6ff1ab51a81365c30faad
P2860
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.